What did @socalurologyinstitute actually say?
Honestly? Almost nothing medically substantive. The transcript is a fragment of a pop song, specifically what appears to be lyrics from "I Gotta Feeling" by the Black Eyed Peas, paired with a caption claiming "My estradiol is 70 on TRT; I don't care." The clinical content lives in the caption, not the words spoken. So the actual medical claim being broadcast to 53,000+ viewers is: an estradiol level of 70 pg/mL during testosterone replacement therapy is not worth worrying about, and by extension, neither is estrogen management generally.
That framing, delivered with a song and a shrug, carries real weight when it comes from an account branding itself as a urology institute. The hashtags for arimidex and anastrozole suggest the implicit subtext is that aromatase inhibitors are unnecessary. That's the claim worth examining.
Does the science back this up?
Partially, and only in specific contexts. The evidence that moderate estradiol elevation during TRT causes harm is genuinely weaker than many TRT clinics have historically implied. But "I don't care" at 70 pg/mL glosses over real nuance.
The often-cited "normal" male estradiol range runs roughly 10-40 pg/mL on standard assays, though the more accurate liquid chromatography-mass spectrometry (LC-MS/MS) assay shifts those goalposts. Travison et al. (2017, Journal of Clinical Endocrinology and Metabolism) found that estradiol plays a key role in male libido and bone density, and that suppressing it aggressively with aromatase inhibitors actually worsens outcomes. Finkelstein et al. (2013, NEJM) demonstrated that both testosterone and estradiol contribute independently to sexual function and body composition in men. So the "estrogen is always the enemy" narrative that has driven aggressive AI prescribing in TRT clinics is not well supported.
However, estradiol at 70 pg/mL is not nothing. Some men are symptomatic at that level, some are not. Individual variation is large, assay type matters enormously, and blanket dismissal is not the same as evidence-based reassurance.
What did they get wrong (or right)?
They get partial credit for pushing back against reflexive estrogen suppression. The TRT community has over-relied on aromatase inhibitors for years, often based on symptom checklists with poor specificity and the unsupported assumption that any estradiol above 30 pg/mL needs correction. Ramasamy et al. (2014, BJU International) showed that anastrozole use in hypogonadal men produced testosterone increases but raised concerns about lipid profiles and bone metabolism with long-term use.
Where this video fails is in the delivery. A blanket "I don't care" communicated to tens of thousands of people managing their own TRT, many without close clinical supervision, is irresponsible framing. Estradiol at 70 pg/mL can be associated with gynecomastia progression in predisposed individuals, and context like breast tissue sensitivity, cardiovascular history, and assay methodology genuinely matters. Dismissing it without those caveats teaches the wrong lesson, even if the lesson adjacent to it has some merit.
What should you actually know?
If you are on TRT and your estradiol comes back elevated, the first question is what assay was used. Standard immunoassay estradiol tests are not validated for men and frequently read falsely high. The LC-MS/MS assay is the appropriate test for men. Many "high" estradiol results in TRT patients are assay artifacts.
Second, symptoms matter more than a number in isolation. Gynecomastia, water retention, or mood changes paired with an elevated estradiol is a different clinical picture than an elevated number with no symptoms.
Third, aromatase inhibitors like anastrozole carry real risks. They are not benign estrogen-management tools. Long-term use can negatively affect bone mineral density, lipid profiles, and cognitive function. Aggressive use to chase an arbitrary estradiol target is not supported by current evidence.
Finally, individual thresholds vary. A level of 70 pg/mL might be genuinely fine for one patient and clinically relevant for another. Anyone managing TRT without a physician who actually reviews labs in context is taking on real risk, regardless of what a urology-branded TikTok account posts.